99% Savings - Buy Just @1 Rs X
Pexopram 1 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Parkinson's Disease. Other than this, Pexopram 1 Tablet has some other therapeutic uses, which have been discussed ahead.
The right dosage of Pexopram 1 Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Pexopram 1 Tablet can also lead to other problems, which have been listed below. Such side effects of Pexopram 1 Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Pexopram 1 Tablet's effect during pregnancy is Moderate and Severe while nursing. It is important to know if Pexopram 1 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Pexopram 1 Tablet related warnings section.
Pexopram 1 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Schizophrenia, Heart Disease, Kidney Disease are examples of such conditions.
Drug interactions for Pexopram 1 Tablet have been reported in the medical literature. Refer to the list below for further details.
In addition to these precautions, you may also note that Pexopram 1 Tablet is not safe while driving, and is is not addictive in nature.
Pexopram 1 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Pexopram 1 Tablet safe for pregnant women?
Pexopram can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Pexopram right away. Take your doctor's advice before taking it again.
Is the use of Pexopram 1 Tablet safe during breastfeeding?
Pexopram should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Pexopram 1 Tablet on the Kidneys?
Pexopram has very mild side effects on the kidneys.
What is the effect of Pexopram 1 Tablet on the Liver?
Pexopram is completely safe for the liver.
What is the effect of Pexopram 1 Tablet on the Heart?
Side effects of Pexopram rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Pexopram 1 Tablet unless your doctor advises you to do so -
Is this Pexopram 1 Tablet habit forming or addictive?
No, you will not get addicted to Pexopram 1 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
After taking Pexopram 1 Tablet, you should not drive or work on any heavy machine, as Pexopram 1 Tablet can make you drowsy.
Is it safe?
Yes, but take Pexopram 1 Tablet only as per medical advice.
Is it able to treat mental disorders?
Yes, this Pexopram 1 Tablet works for mental disorders.
Interaction between Food and Pexopram 1 Tablet
Some foods when eaten with Pexopram 1 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Pexopram 1 Tablet
Consumption of alcohol and Pexopram 1 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Mirapex® (pramipexole dihydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1043-1044
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431